FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801630906> ?p ?o ?g. }

• W2801630906 endingPage "162" @default.
• W2801630906 startingPage "157" @default.
• W2801630906 abstract "Myelodysplastic syndrome (MDS) is a diverse group of clonal hematologic neoplasms. The only curative treatment for MDS is allogeneic stem cell transplantation (SCT). Epigenetic changes play an important role in the pathogenesis of MDS and treatment with DNA methyl transferase inhibitors, Azacitidine, significantly prolong the survival of high-risk MDS patients. Here we report a case of a 58-year-old male presented with pancytopenia, macrocytosis, and hyperplastic bone marrow with 3-lineage dysplasia with ~14% of myeloid blasts. Cytogenetic studies with G banding showed normal karyotype. Multiplex ligation-dependent probe amplification (MLPA) screening for most predictive cytogenetic abnormalities of MDS showed loss of the Y chromosome. Those findings later were confirmed with Quantitative Fluorescent (QF)-PCR and specific MLPA for Y chromosome, showing loss of the Y chromosome in >80% of cells. He was diagnosed with MDS-RAEB2 according to 2008 WHO classification and stratified into high risk group (IPSS score 5). Unrelated allogeneic SCT was planed and bridging treatment with Azacitidine at a dose of 75mg/m2/daily subcutaneously for 7 days every 28 days was initiated. Hematologic improvements, according to the International Working Group 2006 criteria, were observed after 4 cycles of Azacitidine treatment. After 6 cycles, complete hematological remission was achieved. Interestingly, molecular analysis performed after the 8th cycle showed normal presence of Y chromosome indicating a cytogenetic remission, molecularly confirmed. Maintenance treatment with Azacitidine was assigned, and the scheduled SCT was postponed. Experience from our case showed that the loss of the Y chromosome was related to the disease onset, and indicated that Azacitidine might be consider as effective treatment for MDS cases associated with good cytogenetic." @default.
• W2801630906 created "2018-05-17" @default.
• W2801630906 creator A5005484305 @default.
• W2801630906 creator A5032295772 @default.
• W2801630906 creator A5037585954 @default.
• W2801630906 creator A5044120317 @default.
• W2801630906 creator A5070629257 @default.
• W2801630906 creator A5074435079 @default.
• W2801630906 creator A5079817340 @default.
• W2801630906 creator A5079967189 @default.
• W2801630906 creator A5083385263 @default.
• W2801630906 creator A5088412114 @default.
• W2801630906 date "2017-12-01" @default.
• W2801630906 modified "2023-10-06" @default.
• W2801630906 title "Moleculary Confirmed, Cytogenetic Remission in a Case with Myelodysplastic Syndrome Treated with Azacitidne" @default.
• W2801630906 cites W187238933 @default.
• W2801630906 cites W1985823023 @default.
• W2801630906 cites W2015776863 @default.
• W2801630906 cites W2050200195 @default.
• W2801630906 cites W2096638244 @default.
• W2801630906 cites W2118771330 @default.
• W2801630906 cites W2129510594 @default.
• W2801630906 cites W2148968593 @default.
• W2801630906 cites W2166403107 @default.
• W2801630906 cites W2222141405 @default.
• W2801630906 cites W2326726820 @default.
• W2801630906 cites W4232645703 @default.
• W2801630906 cites W4248363598 @default.
• W2801630906 doi "https://doi.org/10.2478/prilozi-2018-0017" @default.
• W2801630906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29668469" @default.
• W2801630906 hasPublicationYear "2017" @default.
• W2801630906 type Work @default.
• W2801630906 sameAs 2801630906 @default.
• W2801630906 citedByCount "0" @default.
• W2801630906 crossrefType "journal-article" @default.
• W2801630906 hasAuthorship W2801630906A5005484305 @default.
• W2801630906 hasAuthorship W2801630906A5032295772 @default.
• W2801630906 hasAuthorship W2801630906A5037585954 @default.
• W2801630906 hasAuthorship W2801630906A5044120317 @default.
• W2801630906 hasAuthorship W2801630906A5070629257 @default.
• W2801630906 hasAuthorship W2801630906A5074435079 @default.
• W2801630906 hasAuthorship W2801630906A5079817340 @default.
• W2801630906 hasAuthorship W2801630906A5079967189 @default.
• W2801630906 hasAuthorship W2801630906A5083385263 @default.
• W2801630906 hasAuthorship W2801630906A5088412114 @default.
• W2801630906 hasBestOaLocation W28016309061 @default.
• W2801630906 hasConcept C104317684 @default.
• W2801630906 hasConcept C109748351 @default.
• W2801630906 hasConcept C126322002 @default.
• W2801630906 hasConcept C143998085 @default.
• W2801630906 hasConcept C150194340 @default.
• W2801630906 hasConcept C174475383 @default.
• W2801630906 hasConcept C190727270 @default.
• W2801630906 hasConcept C2775894508 @default.
• W2801630906 hasConcept C2776239401 @default.
• W2801630906 hasConcept C2779142324 @default.
• W2801630906 hasConcept C2779382419 @default.
• W2801630906 hasConcept C2780007613 @default.
• W2801630906 hasConcept C2780240888 @default.
• W2801630906 hasConcept C2780817109 @default.
• W2801630906 hasConcept C30481170 @default.
• W2801630906 hasConcept C53226629 @default.
• W2801630906 hasConcept C54355233 @default.
• W2801630906 hasConcept C71924100 @default.
• W2801630906 hasConcept C86803240 @default.
• W2801630906 hasConcept C90924648 @default.
• W2801630906 hasConceptScore W2801630906C104317684 @default.
• W2801630906 hasConceptScore W2801630906C109748351 @default.
• W2801630906 hasConceptScore W2801630906C126322002 @default.
• W2801630906 hasConceptScore W2801630906C143998085 @default.
• W2801630906 hasConceptScore W2801630906C150194340 @default.
• W2801630906 hasConceptScore W2801630906C174475383 @default.
• W2801630906 hasConceptScore W2801630906C190727270 @default.
• W2801630906 hasConceptScore W2801630906C2775894508 @default.
• W2801630906 hasConceptScore W2801630906C2776239401 @default.
• W2801630906 hasConceptScore W2801630906C2779142324 @default.
• W2801630906 hasConceptScore W2801630906C2779382419 @default.
• W2801630906 hasConceptScore W2801630906C2780007613 @default.
• W2801630906 hasConceptScore W2801630906C2780240888 @default.
• W2801630906 hasConceptScore W2801630906C2780817109 @default.
• W2801630906 hasConceptScore W2801630906C30481170 @default.
• W2801630906 hasConceptScore W2801630906C53226629 @default.
• W2801630906 hasConceptScore W2801630906C54355233 @default.
• W2801630906 hasConceptScore W2801630906C71924100 @default.
• W2801630906 hasConceptScore W2801630906C86803240 @default.
• W2801630906 hasConceptScore W2801630906C90924648 @default.
• W2801630906 hasIssue "3" @default.
• W2801630906 hasLocation W28016309061 @default.
• W2801630906 hasLocation W28016309062 @default.
• W2801630906 hasOpenAccess W2801630906 @default.
• W2801630906 hasPrimaryLocation W28016309061 @default.
• W2801630906 hasRelatedWork W2007065404 @default.
• W2801630906 hasRelatedWork W2010886199 @default.
• W2801630906 hasRelatedWork W2025908815 @default.
• W2801630906 hasRelatedWork W2089655159 @default.
• W2801630906 hasRelatedWork W2127815926 @default.
• W2801630906 hasRelatedWork W2146254357 @default.
• W2801630906 hasRelatedWork W2391441308 @default.

• next